Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
  1. 4 Planned sale Director sold 7,229 shares at $39.66 ($286,715)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 1,211 shares (option exercise)
  8. 4 Planned sale GENERAL COUNSEL & CORP SEC sold 3,978 shares at an average $32.28 ($128,411)
  9. 4 Planned sale Director sold 13,430 shares at an average $32.27 ($433,385)
  10. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,358 shares at an average $31.19 ($167,115)
  11. 4 Planned sale Director sold 15,001 shares at an average $31.13 ($466,959)
  12. 4 Planned sale GENERAL COUNSEL & CORP SEC sold 9,803 shares at an average $31.25 ($306,322)
  13. 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,020 shares at an average $30.22 ($121,468)
  14. 4 Open-market sale Director sold 2,136 shares at an average $30.22 ($64,541)
  15. 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 4,576 shares at an average $30.22 ($138,268)
  16. 4 Planned sale Director sold 40,472 shares at $29.72 ($1,202,719)
  17. 4 Planned sale Director sold 40,472 shares at an average $26.98 ($1,092,058)
  18. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,931 shares at an average $25.72 ($152,566)
  19. 4 Derivatives Options or other derivatives
  20. 4 Planned sale Director sold 25,000 shares at $30.00 ($750,000)

Page 3 of 16 · 305 filings